PMID- 21035858 OWN - NLM STAT- MEDLINE DCOM- 20101210 LR - 20101124 IS - 1872-9142 (Electronic) IS - 0161-5890 (Linking) VI - 47 IP - 16 DP - 2010 Oct TI - Role of interleukin-18 in human natural killer cell is associated with interleukin-2. PG - 2604-10 LID - 10.1016/j.molimm.2010.05.290 [doi] AB - Human natural killer (NK) cells constitute an important cellular component of innate immunity, capable of killing infected and transformed cells. The proliferation and activation of NK cells are regulated by various cytokines. Interleukin-18 (IL-18) promotes NK cell activation; however, whether the effects of IL-18 on NK cell are associated with other cytokines is still unknown. In this study, we observed that IL-18 induced NK cell apoptosis and inhibited NK cell expansion in the presence of low concentrations of interleukin-2 (IL-2), while high concentrations of IL-2 overcame these effects of IL-18, and high concentrations of IL-2 promoted the stimulatory activity of IL-18 on NK cells. At a low concentration of IL-2, IL-18 induced NK cell apoptosis in part through activation of the FasL/Fas- and TNFalpha/TNFR-mediated death receptor signaling by enhancing FasL expression and inhibiting c-FLIP(long) expression. However, high concentrations of IL-2 strongly blocked IL-18-induced NK cell apoptosis through alleviating IL-18-induced FasL expression and activation of Fas-mediated death signaling and increasing anti-apoptosis molecule (Bcl-X(L)). These results reveal that the effects of IL-18 on human NK cell are associated with IL-2 concentration and suggest the importance of IL-2 level in cytokine immunotherapy. CI - Published by Elsevier Ltd. FAU - Huang, Yong AU - Huang Y AD - Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20892, USA. FAU - Lei, YingFeng AU - Lei Y FAU - Zhang, Hai AU - Zhang H FAU - Zhang, Mingjie AU - Zhang M FAU - Dayton, Andrew AU - Dayton A LA - eng PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20101030 PL - England TA - Mol Immunol JT - Molecular immunology JID - 7905289 RN - 0 (CASP8 and FADD-Like Apoptosis Regulating Protein) RN - 0 (CFLAR protein, human) RN - 0 (Fas Ligand Protein) RN - 0 (IL2 protein, human) RN - 0 (Interleukin-18) RN - 0 (Interleukin-2) SB - IM MH - Apoptosis MH - CASP8 and FADD-Like Apoptosis Regulating Protein/immunology MH - Cells, Cultured MH - Fas Ligand Protein/immunology MH - Humans MH - Interleukin-18/*immunology MH - Interleukin-2/*immunology MH - Killer Cells, Natural/cytology/*immunology EDAT- 2010/11/03 06:00 MHDA- 2010/12/14 06:00 CRDT- 2010/11/02 06:00 PHST- 2010/04/12 00:00 [received] PHST- 2010/05/27 00:00 [accepted] PHST- 2010/11/02 06:00 [entrez] PHST- 2010/11/03 06:00 [pubmed] PHST- 2010/12/14 06:00 [medline] AID - S0161-5890(10)00467-0 [pii] AID - 10.1016/j.molimm.2010.05.290 [doi] PST - ppublish SO - Mol Immunol. 2010 Oct;47(16):2604-10. doi: 10.1016/j.molimm.2010.05.290. Epub 2010 Oct 30.